EMBC GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Embecta Corp
Exchange: NASDAQSector: HealthcareIndustry: Medical Instruments & Supplies
Embecta Corp
Current Price
$3.14
+0.00%GoodMoat Value
$14.57
364.1% undervaluedProfile
Valuation (TTM)
Market Cap$185.95M
P/E1.66
EV—
P/B—
Shares Out59.22M
P/Sales0.18
Revenue$1.04B
EV/EBITDA4.22
Embecta Corp (EMBC) Quality Analysis
EMBC Profitability
Profitability trend analysis coming soon
EMBC Growth
Growth trend analysis coming soon
EMBC Financial Health
Financial health indicators coming soon
EMBC Quality & Fundamental Analysis
Embecta Corp (EMBC) is a Healthcare company in the Medical Instruments & Supplies industry, listed on NASDAQ. This quality analysis page evaluates Embecta Corp's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Embecta Corp has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 10.73%. Return on assets (ROA) stands at 10.26%.
with a current ratio of 2.41. Operating margin is 22.41%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Embecta Corp is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.